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Abstract
Introduction: Hypernatremia is common among hospitalized patients especially in the intensive care units and presents an independent risk factor 
for mortality. Mild hypernatremia is often asymptomatic but severe hypernatremia causes central nervous system dysfunction with initial non-spe-
cific symptoms of encephalopathy that may progress to seizures, coma and death, if left untreated. Severe hypernatremia is a medical emergency 
and requires emergent medical attention.
Materials and methods: A haemodialysis patient who arrived for his scheduled haemodialysis treatment had monthly blood work drawn and was 
reported to have severe hypernatremia with serum sodium concentration of 183 mmol/L. The possibility of technique or laboratory error was consi-
dered and systematically evaluated. 
Results: The serum sodium measurement using another analyser showed similar value of 182 mmolL. A repeat serum sodium level on a sample 
drawn 2 h later showed normal value of 139–140 mmol/L. A step-wise evaluation of the complete procedure from blood collection to analysis of the 
sample revealed this to be spuriously elevated serum sodium concentration secondary to contamination of the sample during sample collection with 
trisodium citrate, a catheter-lock solution, commonly used in dialysis units to maintain patency of dialysis catheters. 
Conclusions: Spuriously elevated plasma sodium concentration (pseudohypernatremia) of mild degree is common but severe pseudohypernatre-
mia is rare and the possibility of sample contaminations or laboratory error should be considered. Vigilance is required by both the medical and the 
laboratory staff to resolve such issues in a timely fashion to avoid unintended consequences. 
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Hypernatremia represents an abnormal ratio of to-
tal body sodium to water and is defined as serum 
sodium concentration of over 145 mmol/L (1). Hy-
pernatremia is common among hospitalized pa-
tients, with a prevalence of approximately 0.5% to 
2% (1-3) in general wards, but affecting 10 to 26% 
of patients in intensive care units (4,5) and is an in-
dependent risk factor for mortality among inten-
sive care patients with mortality rates of 30% to 
70% (1-3,5,6). 
Many factors, alone or in combination, influence 
the ratio of sodium to water. Rarely excess sodium 
intake (7) can cause hypernatremia, but most cas-
es are due to either insufficient water intake or hy-
potonic fluid losses, that could be renal or extra-
renal (excessive sweating or diarrhea). Based on 
serum sodium level, hypernatremia may be mild 
(145 - 150 mmol/L), moderate (151 - 155 mmol/L) or 
severe (> 155 mmol/L). Mild hypernatremia is of-
ten asymptomatic, but severe hypernatremia, like 
severe hyponatremia, causes central nervous sys-
tem dysfunction with initial non-specific symp-
toms of encephalopathy (lethargy, headache, nau-
sea, confusion) that may progress to seizures, 
coma and death; if left untreated (6). Thus, severe 
hypernatremia, like severe hyponatremia, is a 
medical emergency and requires emergent medi-
cal attention. We report a case of severe pseudo-
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hypernatremia in a haemodialysis patient second-
ary to trisodium citrate contamination during sam-
ple collection where due diligence and systematic 




A 61-year old man with chronic kidney disease had 
been receiving maintenance haemodialysis three 
times a week for past 2-years. He came for his 
scheduled haemodialysis treatment. He receives 
haemodialysis through a right internal jugular per-
manent catheter (Perm-Cath). He had monthly 
blood work done and the laboratory called an 
alert, as the serum sodium was 183 mmol/L (Table 
1) and required immediate attention. Patient was 
assessed at this time and he denied symptoms of 
headache or nausea. He was alert and oriented. 
His medications were lisinopril 10 mg a day; seve-
lamer hydrochloride 800 mg three times a day and 
erythropoietin. Physical examination was unre-
markable. Patient was undergoing the dialysis 
therapy, without any issues. A repeat sample for 
serum sodium was normal with serum sodium of 
140 mmol/L. He completed the dialysis treatment 
uneventfully. 
Methods
All haemodialysis patients undergo monthly blood 
work to assess dialysis adequacy, haemoglobin 
levels, nutritional and metabolic parameters. 
Blood sample for chemistry, including electrolytes 
were drawn, as per standard protocol (Table 2) by 
the nursing staff of the dialysis unit, using stand-
ard plasma tubes with gel separator and lithium 
heparin (BD PSTTM II, Becton, Dickinson and Com-
pany, Franklin, New Jersey, USA) and sent to the 
laboratory situated within the hospital.
Trisodium citrate 4% (140 mmol/L citrate and 420 
mmol sodium/L) solution (Citra-LockTM, Dirinco, 
Rosamalen, Netherlands) is used at our centre to 
lock the central venous catheters (both temporary 
and permanent catheters) to maintain their paten-
cy. We use pre-filled syringes that contain 3.0 mL 
of 4% trisodium citrate (CitraFlowTM, Emergo-Eu-
rope, Hague, Netherlands). A volume of 1.7 to 1.9 
mL of this solution is instilled in each lumen of the 
catheter at the end of each dialysis treatment to 
maintain patency of the catheter during the inter-
dialytic period.
The laboratory uses the Siemens Advia 1200 ana-
lyser for serum electrolytes that uses Ion Selective 
Electrode (ISE) principle to measure serum sodium 
level. Lithium levels were also measured using the 
same machine. The same analyser (Siemens Advia 
1200 A, Erlangen, Germany) was used to measure 
serum sodium in all samples. Whenever there is a 
discrepancy or discordant results, the laboratory 
staff runs the samples on a different analyser (Sie-
mens Advia 1200 B, Erlangen, Germany) to assure 
accuracy and to rule out a technical issue.
Two days later, at the next scheduled dialysis ses-
sion before initiating dialysis therapy, two separate 
blood samples were drawn from the dialysis cath-
eter. One sample was drawn directly from the 
catheter without discarding 5 mL of blood from 
the catheter lumen (label “C” - contaminated sam-
ple with catheter-lock solution, CitraFlowTM) and an-
other blood sample was drawn after discarding 
initial 5 mL of blood from each catheter lumen (la-
bel “P” – protocol based blood sample). Both sam-
ples were sent to the laboratory with instructions 
to perform serum electrolytes. 
Results
The serum sodium levels in all other samples per-
formed at the same time were within normal range, 
except for this individual. After alerting the dialysis 
unit of a critical laboratory value, the laboratory 
staff ran this individuals blood specimen on a differ-
ent analyser (Siemens Advia 1200 B), as per protocol 
of a discordant result, to assure accuracy and noted 
similar results (Table 1). Repeat serum sodium level, 
2-hours later, using the same analysers showed a 
normal value. The serum albumin was normal at 38 
g/L. The lithium level was not elevated.
The serum sodium concentration was 220 mmol/L 
in sample “C” compared to normal serum sodium 
concentration of 140 mmol/L in sample “P” (Table 1). 
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Sample “C” drawn directly* 
from dialysis catheter
Sample “P” drawn from 






183 183 140 139 220 140
Siemens
Advia B




(mmol/L) Advia A 3.5–5.0 4.8 4.6 2.8
# 4.1
Chloride 
(mmol/L) Advia A 99–109 87 88 65
# 100
Lithium 
(mmol/L) Advia A 0.77 0.94
*Direct sample “C” was drawn from the dialysis catheter without discarding the initial 5mL of blood from the lumen of the 
catheter, and is contaminated with catheter lock solution, trisodium citrate.
#The low values of serum potassium and chloride in sample “C” are artifactual because about 1.5ml of 4.5 ml (or 1/3) of blood 
sample is the residual amount of trisodium citrate present in the lumen of the catheter and these values represent about 2/3 of 
normal values.
Table 1. Laboratory results at different times during assessment
Under aseptic condition:
•	 Using a 10 ml syringe, withdraw catheter-lock solution (heparin or sodium citrate) from the arterial port of the catheter, along 
with blood to a total of 5 mL. Discard the contents of the syringe in a bio-hazardous container.
•	 Connect a new syringe or collection vacutainer device and fill to desired level of blood volume.
•	 Proceed with treatment initiation according to protocol.
Table 2. Protocol for blood sample collection from haemodialysis catheter
Discussion
Mild degree of spuriously elevated serum sodium 
(pseudohypernatremia)  is common and is often 
due to decreased plasma proteins (8). However, se-
vere pseduohypernatremia is rare. There are only a 
handful of case reports in the literature, and none 
has been reported secondary to contamination 
with trisodium citrate. Gaylord et al. in 1991 report-
ed factitious hypernatremia and hyperkalemia 
secondary to the release of benzalkonium chloride 
(BZK) from heparin-bonded umbilical catheters 
(9). Either heparin or trisodium citrate is used as 
catheter lock solutions during the interdialytic pe-
riod to maintain the patency of the central venous 
catheters. Sodium citrate, in addition to its antico-
agulant activity also has antibacterial activity (10) 
and is the preferred catheter-lock solution (11) in 
many centres including our centre, so the likeli-
hood of heparin-associated contamination was 
not likely. The laboratory staff had already exclud-
ed the technical issues with the analyser, as other 
samples ran at the time of index sample showed 
no aberrant or discordant results and when these 
samples were ran on the other analyser showed 
similar results. The contamination of blood sam-
ples from collection tubes (12,13) was considered 
as the soft gel separator in the BD Vacutainer 
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tubes contain lithium heparin, and the possibility 
of lithium leak from the soft gel separator contam-
inating the sample was excluded as there was no 
significant difference in the lithium levels in the in-
dex and the 2-hour sample. Then, the possibility of 
the sample being contaminated with the trisodi-
um citrate, the catheter-lock solution was consid-
ered as a variable part of the catheter locking solu-
tion remains in the catheter (14) that has very high 
sodium concentration. There are established pro-
tocols when drawing blood samples from central 
lines or central venous catheters to prevent con-
tamination of blood samples with catheter-lock 
solutions. This possibility was considered, and at 
his next scheduled dialysis, two blood samples 
(sample “C” and sample “P”) were drawn simulta-
neously as described earlier. The markedly elevat-
ed serum sodium concentration in sample “C” 
highly supports that the initial sample at the time 
of index event was not drawn properly and led to 
the contamination of the sample with trisodium 
citrate.  
This case report illustrates that when in doubt, a 
systematic approach to the issue often results in 
the resolution of the problem at hand. 
In conclusion, severe pseudohypernatremia is rare 
and when it occurs, assay interference or technical 
issues in the specimen collection should be con-
sidered and evaluated systematically. Vigilance is 
required by both the medical and the laboratory 
staff to resolve such issues in a timely fashion to 
avoid unintended consequences.
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